SUNRATE Secures Payment Business Licence In China

SINGAPORE - Media OutReach Newswire - 15 August 2025 - SUNRATE, the global payment and treasury management platform, today announced it has secured a payment business licence in China following its successful acquisition of a 100% stake in Transfar Pay, a unit of Shenzhen-listed Transfar Group. The RMB 315 million (USD 43.8 million) acquisition has received approval from relevant Chinese regulatory authorities. This transaction had been previously announced by the Transfer Group in an exchange filing dated April 1, 2025.

"This acquisition represents a strategic step in SUNRATE's ongoing commitment to enhancing our global licensing framework and ensuring compliant operations in all jurisdictions, whether through direct licensing or strategic partnerships," said Paul Meng, co-founder at SUNRATE.

With the addition of this licence, SUNRATE gains greater access to one of the world's most important and dynamic markets. This further complements SUNRATE's regulatory presence in key jurisdictions including Singapore, Hong Kong SAR, the United Kingdom, and Indonesia, with further regulatory milestones in other jurisdictions to be announced in due course.

Hashtag: #SUNRATE

The issuer is solely responsible for the content of this announcement.

About SUNRATE

SUNRATE is a global payment and treasury management platform for businesses worldwide. Since its inception in 2016, SUNRATE has been recognised as a leading solution provider and has enabled companies to operate and scale both locally and globally in 190+ countries and regions with its cutting-edge proprietary platform, extensive global network, and robust APIs.

With its global business headquarters in Singapore and offices in Hong Kong, Jakarta, London, and Shanghai, SUNRATE partners with the top global financial institutions, such as Citibank, Standard Chartered, Barclays, J.P. Morgan and is the principal member of both Mastercard and Visa. To learn more about SUNRATE, visit https://www.sunrate.com/

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress
• Solana Price Prediction: Pepeto Presale Delivers What SOL’s Recovery Cannot
• Next Crypto to Explode in July 2026 as Bitcoin Bounces From $58K Low and Smart Money Rotates